These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31367681)

  • 1. A comparison of landmark methods and time-dependent ROC methods to evaluate the time-varying performance of prognostic markers for survival outcomes.
    Bansal A; Heagerty PJ
    Diagn Progn Res; 2019; 3():14. PubMed ID: 31367681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Tutorial on Evaluating the Time-Varying Discrimination Accuracy of Survival Models Used in Dynamic Decision Making.
    Bansal A; Heagerty PJ
    Med Decis Making; 2018 Nov; 38(8):904-916. PubMed ID: 30319014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating prognostic accuracy of biomarkers under competing risk.
    Zheng Y; Cai T; Jin Y; Feng Z
    Biometrics; 2012 Jun; 68(2):388-96. PubMed ID: 22150576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic thresholds and a summary ROC curve: Assessing prognostic accuracy of longitudinal markers.
    Saha-Chaudhuri P; Heagerty PJ
    Stat Med; 2018 Aug; 37(18):2700-2714. PubMed ID: 29671890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
    Lai J; Yang H; Xu T
    BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk-based measure of time-varying prognostic discrimination for survival models.
    Liang CJ; Heagerty PJ
    Biometrics; 2017 Sep; 73(3):725-734. PubMed ID: 27893925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination measures for survival outcomes: connection between the AUC and the predictiveness curve.
    Viallon V; Latouche A
    Biom J; 2011 Mar; 53(2):217-36. PubMed ID: 21308725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers.
    Zheng Y; Cai T; Feng Z
    Biometrics; 2006 Mar; 62(1):279-87. PubMed ID: 16542256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals.
    Barton TJ; Low DA; Bakker EA; Janssen T; de Groot S; van der Woude L; Thijssen DHJ
    Arch Phys Med Rehabil; 2021 Jan; 102(1):27-34. PubMed ID: 32861666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary measure of discrimination in survival models based on cumulative/dynamic time-dependent ROC curves.
    Lambert J; Chevret S
    Stat Methods Med Res; 2016 Oct; 25(5):2088-2102. PubMed ID: 24395866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging hybrid biomarkers in clinical endpoint prediction.
    Saad M; Lee IH
    BMC Med Inform Decis Mak; 2020 Oct; 20(1):255. PubMed ID: 33028301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-varying discrimination accuracy of longitudinal biomarkers for the prediction of mortality compared to assessment at fixed time point in severe burns patients.
    Yoon J; Kym D; Hur J; Won JH; Yim H; Cho YS; Chun W
    BMC Emerg Med; 2021 Jan; 21(1):1. PubMed ID: 33407163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Time related receiver operation characteristic curves and its application in clinical trials and diagnostic analysis].
    Zhao YY; Zhao W; Wang ZY; Li W; Wang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jun; 37(6):891-4. PubMed ID: 27346123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semiparametric estimation of time-dependent ROC curves for longitudinal marker data.
    Zheng Y; Heagerty PJ
    Biostatistics; 2004 Oct; 5(4):615-32. PubMed ID: 15475423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent ROC curve analysis in medical research: current methods and applications.
    Kamarudin AN; Cox T; Kolamunnage-Dona R
    BMC Med Res Methodol; 2017 Apr; 17(1):53. PubMed ID: 28388943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.
    Stockmann J; Verberk IMW; Timmesfeld N; Denz R; Budde B; Lange-Leifhelm J; Scheltens P; van der Flier WM; Nabers A; Teunissen CE; Gerwert K
    Alzheimers Res Ther; 2020 Dec; 12(1):169. PubMed ID: 33357241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Risk Score to the Prediction of 10-year Risk for Coronary Artery Disease Among the Elderly in Beijing Based on Competing Risk Model.
    Liu L; Tang Z; Li X; Luo Y; Guo J; Li H; Liu X; Tao L; Yan A; Guo X
    Medicine (Baltimore); 2016 Mar; 95(11):e2997. PubMed ID: 26986112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two correlated ROC curves at a given specificity or sensitivity level.
    Bantis LE; Feng Z
    Stat Med; 2016 Oct; 35(24):4352-4367. PubMed ID: 27324068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.